Cleveland Clinic adopts On-X LTI Technologies' heart valve tool
On-X LTI Technologies, a heart valve product provider, has entered into a license agreement with the Cleveland Clinic in Ohio to develop a system of surgical tools that will facilitate the replacement process of a severed mitral valve chordate.
According to the Austin, Texas-based company, surgical repair of the mitral valve consists of an insertion of a cloth-covered ring around the valve to bring the leaflets into contact with each other (annuloplasty), removal of loose segments of the leaflets and re-suspension of the leaflets with artificial cords (chordal replacement).
Marc Gillinov, MD, a cardiac surgeon at the Cleveland Clinicsaid that with the current techniques, "chordal replacement is technically challenging. The hope is to assist cardiac surgeons by providing a simple method for chordal replacement.”
According to the company, the surgical products will be co-invented by Gillinov and Michael K. Banbury, MD, of Christina Care’s Center for Heart and Vascular Health in Wilmington, Del., in cohorts with On-X LTI’s product development team.
According to the Austin, Texas-based company, surgical repair of the mitral valve consists of an insertion of a cloth-covered ring around the valve to bring the leaflets into contact with each other (annuloplasty), removal of loose segments of the leaflets and re-suspension of the leaflets with artificial cords (chordal replacement).
Marc Gillinov, MD, a cardiac surgeon at the Cleveland Clinicsaid that with the current techniques, "chordal replacement is technically challenging. The hope is to assist cardiac surgeons by providing a simple method for chordal replacement.”
According to the company, the surgical products will be co-invented by Gillinov and Michael K. Banbury, MD, of Christina Care’s Center for Heart and Vascular Health in Wilmington, Del., in cohorts with On-X LTI’s product development team.